Semler Scientific Inc (OQ:SMLR)

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 2340-2348 Walsh Avenue, Suite 2344
SANTA CLARA CA 95051
Tel: N/A
Website: https://www.semlerscientific.com
IR: See website
<
Key People
Douglas Murphy-Chutorian
President and Interim Chief Executive Officer 		Renae Cormier
Chief Financial Officer, Chief Accounting Officer 		Andrew B. Weinstein
Senior Vice President - Finance and Accounting
Daniel E. Conger
Vice President - Finance 		   
Business Overview
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
Financial Overview
For the fiscal year ended 31 December 2023, Semler Scientific Inc revenues increased 20% to $68.2M. Net income increased 44% to $20.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest and dividend income increase from $494K to $2.5M (income), Other income (expenses) increase from $5K (expense) to $17K (income).
Employees: 92 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $123.71M as of Dec 31, 2023
Annual revenue (TTM): $68.18M as of Dec 31, 2023
EBITDA (TTM): $23.23M as of Dec 31, 2023
Net annual income (TTM): $20.58M as of Dec 31, 2023
Free cash flow (TTM): $20.50M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 7,031,083 as of Mar 1, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.

Learn More